Hi,
we did not dilute the CAV2-Cre stock that we received from the Biocampus core at Montpellier. They stated 2.5 10e12 pp/mL
We learned about this from the following paper:
Boender AJ, de Jong JW, Boekhoudt L, Luijendijk MCM, van der Plasse G, et al. (2014) Combined Use of the Canine Adenovirus-2 and DREADD- Technology to Activate Specific Neural Pathways In Vivo. PLoS ONE 9(4): e95392. doi:10.1371/journal.pone.0095392
We hope this is useful.
Thanks,
Lucas
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.